The mark of CML is the presence of shortened Philadelphia chromosome (Ph) that occurs due to reciprocal translocation between chromosome 9 and chromosome 22 [(9;22) (q34;q11)], thereby eventually culminating in the genesis of the BCR-ABL oncogene. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.